Vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations: study protocol for a phase IIB randomized controlled trial

BACKGROUND: Vancomycin is the standard first-line treatment for methicillin-resistant Staphylococcus aureus bacteremia. However, recent consensus guidelines recommend that clinicians consider using alternative agents such as daptomycin when the vancomycin minimum inhibitory concentration is greater...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalimuddin, Shirin, Phillips, Rachel, Gandhi, Mihir, de Souza, Nurun Nisa, Low, Jenny GH, Archuleta, Sophia, Lye, David, Tan, Thuan Tong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081513/
https://www.ncbi.nlm.nih.gov/pubmed/24943129
http://dx.doi.org/10.1186/1745-6215-15-233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081513/
https://www.ncbi.nlm.nih.gov/pubmed/24943129
http://dx.doi.org/10.1186/1745-6215-15-233

Ejemplares similares